179 related articles for article (PubMed ID: 30080749)
1. Interatrial Shunting, a Novel Device-Based Therapy for Patients With Heart Failure.
Yum BKW; Frishman WH
Cardiol Rev; 2018; 26(5):267-273. PubMed ID: 30080749
[TBL] [Abstract][Full Text] [Related]
2. Creation of a restrictive atrial left-to-right shunt: a novel treatment for heart failure.
De Rosa R; Schranz D
Heart Fail Rev; 2018 Nov; 23(6):841-847. PubMed ID: 30267205
[TBL] [Abstract][Full Text] [Related]
3. Unidirectional left-to-right interatrial shunting for treatment of patients with heart failure with reduced ejection fraction: a safety and proof-of-principle cohort study.
Del Trigo M; Bergeron S; Bernier M; Amat-Santos IJ; Puri R; Campelo-Parada F; Altisent OA; Regueiro A; Eigler N; Rozenfeld E; Pibarot P; Abraham WT; Rodés-Cabau J
Lancet; 2016 Mar; 387(10025):1290-7. PubMed ID: 27025435
[TBL] [Abstract][Full Text] [Related]
4. Rationale and Design of the Reduce Elevated Left Atrial Pressure in Patients With Heart Failure (Reduce LAP-HF) Trial.
Hasenfuss G; Gustafsson F; Kaye D; Shah SJ; Burkhoff D; Reymond MC; Komtebedde J; Hünlich M;
J Card Fail; 2015 Jul; 21(7):594-600. PubMed ID: 26055211
[TBL] [Abstract][Full Text] [Related]
5. Impact of an interatrial shunt device on survival and heart failure hospitalization in patients with preserved ejection fraction.
Kaye DM; Petrie MC; McKenzie S; Hasenfuβ G; Malek F; Post M; Doughty RN; Trochu JN; Gustafsson F; Lang I; Kolodziej A; Westenfeld R; Penicka M; Rosenberg M; Hausleiter J; Raake P; Jondeau G; Bergmann MW; Spelman T; Aytug H; Ponikowski P; Hayward C;
ESC Heart Fail; 2019 Feb; 6(1):62-69. PubMed ID: 30311437
[TBL] [Abstract][Full Text] [Related]
6. Interatrial Shunting for Heart Failure: Early and Late Results From the First-in-Human Experience With the V-Wave System.
Rodés-Cabau J; Bernier M; Amat-Santos IJ; Ben Gal T; Nombela-Franco L; García Del Blanco B; Kerner A; Bergeron S; Del Trigo M; Pibarot P; Shkurovich S; Eigler N; Abraham WT
JACC Cardiovasc Interv; 2018 Nov; 11(22):2300-2310. PubMed ID: 30391390
[TBL] [Abstract][Full Text] [Related]
7. One-Year Safety and Clinical Outcomes of a Transcatheter Interatrial Shunt Device for the Treatment of Heart Failure With Preserved Ejection Fraction in the Reduce Elevated Left Atrial Pressure in Patients With Heart Failure (REDUCE LAP-HF I) Trial: A Randomized Clinical Trial.
Shah SJ; Feldman T; Ricciardi MJ; Kahwash R; Lilly S; Litwin S; Nielsen CD; van der Harst P; Hoendermis E; Penicka M; Bartunek J; Fail PS; Kaye DM; Walton A; Petrie MC; Walker N; Basuray A; Yakubov S; Hummel SL; Chetcuti S; Forde-McLean R; Herrmann HC; Burkhoff D; Massaro JM; Cleland JGF; Mauri L
JAMA Cardiol; 2018 Oct; 3(10):968-977. PubMed ID: 30167646
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and Safety of Inter-Atrial Shunt Devices for Heart Failure With Reduced or Preserved Ejection Fraction: Early Experiences.
Lu D; Zhu J; Liao B
Heart Lung Circ; 2018 Mar; 27(3):359-364. PubMed ID: 28483550
[TBL] [Abstract][Full Text] [Related]
9. A transcatheter intracardiac shunt device for heart failure with preserved ejection fraction (REDUCE LAP-HF): a multicentre, open-label, single-arm, phase 1 trial.
Hasenfuß G; Hayward C; Burkhoff D; Silvestry FE; McKenzie S; Gustafsson F; Malek F; Van der Heyden J; Lang I; Petrie MC; Cleland JG; Leon M; Kaye DM;
Lancet; 2016 Mar; 387(10025):1298-304. PubMed ID: 27025436
[TBL] [Abstract][Full Text] [Related]
10. Interatrial Shunt Devices.
Salah HM; Baratto C; Yaranov DM; Rommel KP; Achanta S; Caravita S; Reddy Vasanthu VK; Fudim M
Heart Fail Clin; 2024 Jan; 20(1):61-69. PubMed ID: 37953022
[TBL] [Abstract][Full Text] [Related]
11. Transcatheter Interatrial Shunt Device for the Treatment of Heart Failure: Rationale and Design of the Randomized Trial to REDUCE Elevated Left Atrial Pressure in Heart Failure (REDUCE LAP-HF I).
Feldman T; Komtebedde J; Burkhoff D; Massaro J; Maurer MS; Leon MB; Kaye D; Silvestry FE; Cleland JG; Kitzman D; Kubo SH; Van Veldhuisen DJ; Kleber F; Trochu JN; Auricchio A; Gustafsson F; Hasenfuβ G; Ponikowski P; Filippatos G; Mauri L; Shah SJ
Circ Heart Fail; 2016 Jul; 9(7):. PubMed ID: 27330010
[TBL] [Abstract][Full Text] [Related]
12. Device therapy with interatrial shunt devices for heart failure with preserved ejection fraction.
Nanayakkara S; Kaye DM
Heart Fail Rev; 2023 Mar; 28(2):281-286. PubMed ID: 35438418
[TBL] [Abstract][Full Text] [Related]
13. Assessment of Predictors of Left Atrial Volume Response to a Transcatheter InterAtrial Shunt Device (from the REDUCE LAP-HF Trial).
Hanff TC; Kaye DM; Hayward CS; Post MC; Malek F; Hasenfuβ G; Gustafsson F; Burkhoff D; Shah SJ; Litwin SE; Kahwash R; Hummel SL; Borlaug BA; Solomon SD; Lam CSP; Komtebedde J; Silvestry FE;
Am J Cardiol; 2019 Dec; 124(12):1912-1917. PubMed ID: 31653352
[TBL] [Abstract][Full Text] [Related]
14. Left atrial decompression through unidirectional left-to-right interatrial shunt for the treatment of left heart failure: first-in-man experience with the V-Wave device.
Amat-Santos IJ; Bergeron S; Bernier M; Allende R; Barbosa Ribeiro H; Urena M; Pibarot P; Verheye S; Keren G; Yaacoby M; Nitzan Y; Abraham WT; Rodés-Cabau J
EuroIntervention; 2015 Jan; 10(9):1127-31. PubMed ID: 24832489
[TBL] [Abstract][Full Text] [Related]
15. Device-based percutaneous treatments to decompress the left atrium in heart failure with preserved ejection fraction.
Riccardi M; Tomasoni D; Vizzardi E; Metra M; Adamo M
Heart Fail Rev; 2023 Mar; 28(2):315-330. PubMed ID: 36402928
[TBL] [Abstract][Full Text] [Related]
16. Transcatheter treatment of heart failure with preserved or mildly reduced ejection fraction using a novel interatrial implant to lower left atrial pressure.
Søndergaard L; Reddy V; Kaye D; Malek F; Walton A; Mates M; Franzen O; Neuzil P; Ihlemann N; Gustafsson F
Eur J Heart Fail; 2014 Jul; 16(7):796-801. PubMed ID: 24961390
[TBL] [Abstract][Full Text] [Related]
17. Atrial shunt device for heart failure with preserved and mildly reduced ejection fraction (REDUCE LAP-HF II): a randomised, multicentre, blinded, sham-controlled trial.
Shah SJ; Borlaug BA; Chung ES; Cutlip DE; Debonnaire P; Fail PS; Gao Q; Hasenfuß G; Kahwash R; Kaye DM; Litwin SE; Lurz P; Massaro JM; Mohan RC; Ricciardi MJ; Solomon SD; Sverdlov AL; Swarup V; van Veldhuisen DJ; Winkler S; Leon MB;
Lancet; 2022 Mar; 399(10330):1130-1140. PubMed ID: 35120593
[TBL] [Abstract][Full Text] [Related]
18. One-Year Outcomes After Transcatheter Insertion of an Interatrial Shunt Device for the Management of Heart Failure With Preserved Ejection Fraction.
Kaye DM; Hasenfuß G; Neuzil P; Post MC; Doughty R; Trochu JN; Kolodziej A; Westenfeld R; Penicka M; Rosenberg M; Walton A; Muller D; Walters D; Hausleiter J; Raake P; Petrie MC; Bergmann M; Jondeau G; Feldman T; Veldhuisen DJ; Ponikowski P; Silvestry FE; Burkhoff D; Hayward C
Circ Heart Fail; 2016 Dec; 9(12):e003662. PubMed ID: 27852653
[TBL] [Abstract][Full Text] [Related]
19. The Atrial Flow Regulator device: expanding the field of interatrial shunting for treating heart failure patients.
Guimarães L; Del Val D; Rodés-Cabau J
EuroIntervention; 2019 Aug; 15(5):398-400. PubMed ID: 31456571
[No Abstract] [Full Text] [Related]
20. Creation of a restrictive atrial communication in heart failure with preserved and mid-range ejection fraction: effective palliation of left atrial hypertension and pulmonary congestion.
Bauer A; Khalil M; Lüdemann M; Bauer J; Esmaeili A; De-Rosa R; Voelkel NF; Akintuerk H; Schranz D
Clin Res Cardiol; 2018 Sep; 107(9):845-857. PubMed ID: 29663123
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
